Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma
Technology appraisal guidance
Reference number: TA865
Published:
Evidence
Review and download supporting evidence. Includes the full guideline if available.